liens 555 55 55 55
Dendritic immunotherapy
Dendritic cell therapy
Dendritic cells are immune cells that process and present antigens (like tumor proteins) to T cells, which can then attack cancer cells.
In dendritic cell therapy:
Dendritic cells are collected from the patient’s blood.
They are exposed to tumor antigens in a lab to "train" them.
The activated cells are then re-injected into the patient.
These dendritic cells present the tumor antigens to T cells, stimulating the immune system to target and destroy cancer cells.
Key pointsin dentritic immunotherapy:
Personalized to the patient.
Mostly used in clinical trials or for specific cancers (like prostate cancer with the approved drug Sipuleucel-T).
Goal: trigger a targeted immune response against cancer.
Dendritic cell therapy
Dendritic cells therapy is a therapy using immune cells that process and present antigens (like tumor proteins) to T cells, which can then attack cancer cells.
Dendritic Immunotherapy
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla euismod condimentum felis vitae efficitur. Sed vel dictum quam, at blandit leo.
Dendritic cell immunotherapy
Dendritic Cell Therapy is a form of personalized cancer treatment that activates the body’s own immune system to recognize and attack cancer cells.